Cellular immunity and immunostimulation in paracoccidioidomycosis

Z N Oliveira1, R C Leão, L C Cucé

  • 1Division of Dermatology, Hospital das Clinicas, University of Sao Paulo Medical School, Brazil.

Insights

Immunostimulation with Paracoccidioides brasiliensis antigen improved clinical and immune responses in paracoccidioidomycosis patients. This scarification therapy shows promise as an effective adjuvant treatment for the fungal infection.

Area of Science:

  • Mycology
  • Immunology
  • Infectious Diseases

Background:

  • Paracoccidioidomycosis is a fungal infection endemic to Latin America.
  • Patients often exhibit compromised immune systems, necessitating novel therapeutic approaches.
  • Current treatments may have limitations, highlighting the need for adjunctive therapies.

Purpose of the Study:

  • To evaluate the clinical and laboratorial effects of immunostimulation using Paracoccidioides brasiliensis antigen in paracoccidioidomycosis patients.
  • To assess the safety and efficacy of scarification with P. brasiliensis antigen as an adjuvant therapy.
  • To investigate immunological changes in patients undergoing immunostimulation.

Main Methods:

  • A study involving 62 Brazilian patients with paracoccidioidomycosis (46 active, 16 cured) between 1982 and 1992.
  • Immunostimulation via scarification with P. brasiliensis antigen was administered to 20 patients.
  • Immunological evaluation included in vivo (intradermal tests, DNCB sensitization) and in vitro (lymphocyte counts, migration inhibition, chemotaxis, phagocytosis) methods.

Main Results:

  • Significant clinical and immunological improvements were observed in the 20 immunostimulated patients.
  • All 20 immunostimulated patients had negative paracoccidioidin intradermal reactions post-treatment.
  • The control group of 42 patients received only clinical follow-up.

Conclusions:

  • Immunostimulation by scarification with P. brasiliensis antigen can serve as a beneficial adjuvant therapy for paracoccidioidomycosis.
  • The observed improvements suggest a potential role for this method in managing the immune deficiencies associated with the disease.
  • Further research may explore optimizing this immunostimulation technique for broader clinical application.

Related Concept Videos

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...